RECRUITING

Triage Survey for Cardiovascular, Obesity, and Related Endocrine Trial Eligibility

Talk to us

Conditions

Cardiovascular DiseasesObesityPreDiabetesDiabetes Type 2Metabolic Syndrome

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

SWIFT-CORE-101 is a single site survey study designed to assess potential participants' eligibility to screen for industry-sponsored clinical trials. A physician will oversee the informed consent process, after which participants will be surveyed on demographics, medical history, comorbidities, and current symptoms. Site staff may collect vital signs, urine drug screens, blood draws, and urine pregnancy tests. A doctor will review medical history with the participant to determine study suitability via clinical interview. The doctor may reach out to the patient's current treating physicians and pharmacies to determine eligibility for clinical trials.

Official Title

Triage Survey for Cardiovascular, Obesity, and Related Endocrine Trial Eligibility (SWIFT-CORE-101)

Quick Facts

Study Start:2024-05-30
Study Completion:2029-04-17
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06412536

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Participant or Legally Authorized Representative has signed an ICF prior to study-specific procedures being performed.
  2. 2. Participant is at least 18 years old.
  1. 1. Participant is pregnant, breast-feeding, or planning to become pregnant.
  2. 2. History of a clinically significant illness which in the investigator's opinion may impact participant safety or the ability to analyze study results.
  3. 3. Moderate or severe substance use disorder within 90 days prior to screen
  4. 4. Any condition that in the investigator's opinion makes a participant unsuitable for the study.
  5. 5. Currently employed by Swift Clinical Research Group, Inc. or any of its subsidiaries, including Brooklyn Clinical Research, or a first-degree relative of an employee.

Contacts and Locations

Study Contact

Ammara Mushtaq, MD
CONTACT
929-203-5879
amushtaq@brooklynclinicalresearch.com
Katherine Azer, MS
CONTACT
929-332-7848
kazer@brooklynclinicalresearch.com

Principal Investigator

Ammara Mushtaq, MD
PRINCIPAL_INVESTIGATOR
Brooklyn Clinical Research

Study Locations (Sites)

Brooklyn Clinical Research
Brooklyn, New York, 11226
United States

Collaborators and Investigators

Sponsor: Brooklyn Clinical Research

  • Ammara Mushtaq, MD, PRINCIPAL_INVESTIGATOR, Brooklyn Clinical Research

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-05-30
Study Completion Date2029-04-17

Study Record Updates

Study Start Date2024-05-30
Study Completion Date2029-04-17

Terms related to this study

Additional Relevant MeSH Terms

  • Cardiovascular Diseases
  • Obesity
  • PreDiabetes
  • Diabetes Type 2
  • Metabolic Syndrome